Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties
- Dreger, Peter
- Michallet, Mauricette
- Bosman, Paul
- Dietrich, Sascha
- Sobh, Mohamad
- Boumendil, Ariane
- Schaap, M.
- Montoto, Silvia
- Schetelig, Johannes
Publication date
January 2019
DOI Publisher
Springer Science and Business Media LLCAbstract
Contains fulltext : 201051.pdf (publisher's version ) (Closed access
Add to ORKG